The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Aprepitant is an antiemetic chemical compound that belongs to a class of drugs called substance P antagonists (SPA). It mediates its effect by blocking the neurokinin 1 (NK1) receptor.
The global Aprepitant market was valued at US$ 75 million in 2023 and is anticipated to reach US$ 95 million by 2030, witnessing a CAGR of 3.8% during the forecast period 2024-2030.
Aprepitant is a medication used for preventing nausea and vomiting caused by chemotherapy. The global market for aprepitant is primarily driven by several factors. The increasing incidence of cancer worldwide is a major driver for the aprepitant market. Chemotherapy is one of the primary treatment modalities for cancer, and nausea and vomiting are common side effects of chemotherapy. Aprepitant has been proven effective in preventing these side effects, making it a vital medication in managing the quality of life for cancer patients. The rising awareness among healthcare professionals and patients about the importance of supportive care in cancer treatment is contributing to the market growth. Improved education and understanding about the side effects of chemotherapy and the availability of medications like aprepitant have led to increased demand. The growing adoption of combination therapies in cancer treatment is driving the demand for aprepitant. Aprepitant is often used in combination with other antiemetic medications to provide a comprehensive approach in preventing chemotherapy-induced nausea and vomiting. The development of generic versions of aprepitant is also contributing to its market growth. Generic versions offer cost savings and improved accessibility for patients, leading to increased adoption. The expansion of healthcare infrastructure, especially in emerging markets, is playing a significant role in driving the global market for aprepitant. As more healthcare facilities and cancer treatment centers are established, the demand for aprepitant is expected to rise. Ongoing research and development activities aimed at exploring new indications and formulations for aprepitant are further driving the market. For example, studies are being conducted to evaluate the efficacy of aprepitant in other conditions associated with nausea and vomiting, such as postoperative nausea and vomiting.
This report aims to provide a comprehensive presentation of the global market for Aprepitant, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Aprepitant.
Report Scope
The Aprepitant market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Aprepitant market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Aprepitant manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck & Co.
Heron Therapeutics
Sandoz
Glenmark Pharmaceuticals
Shanghai Yingrui Biomedical Technology Co., Ltd.
Vea Impex (I) Pvt. Ltd.
Aark Pharmaceuticals
Actiza Pharmaceutical
Aetos Pharma
Segment by Type
Injection
Oral
Segment by Application
Hospital
Drug store
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Aprepitant manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Aprepitant in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Aprepitant is an antiemetic chemical compound that belongs to a class of drugs called substance P antagonists (SPA). It mediates its effect by blocking the neurokinin 1 (NK1) receptor.
The global Aprepitant market was valued at US$ 75 million in 2023 and is anticipated to reach US$ 95 million by 2030, witnessing a CAGR of 3.8% during the forecast period 2024-2030.
Aprepitant is a medication used for preventing nausea and vomiting caused by chemotherapy. The global market for aprepitant is primarily driven by several factors. The increasing incidence of cancer worldwide is a major driver for the aprepitant market. Chemotherapy is one of the primary treatment modalities for cancer, and nausea and vomiting are common side effects of chemotherapy. Aprepitant has been proven effective in preventing these side effects, making it a vital medication in managing the quality of life for cancer patients. The rising awareness among healthcare professionals and patients about the importance of supportive care in cancer treatment is contributing to the market growth. Improved education and understanding about the side effects of chemotherapy and the availability of medications like aprepitant have led to increased demand. The growing adoption of combination therapies in cancer treatment is driving the demand for aprepitant. Aprepitant is often used in combination with other antiemetic medications to provide a comprehensive approach in preventing chemotherapy-induced nausea and vomiting. The development of generic versions of aprepitant is also contributing to its market growth. Generic versions offer cost savings and improved accessibility for patients, leading to increased adoption. The expansion of healthcare infrastructure, especially in emerging markets, is playing a significant role in driving the global market for aprepitant. As more healthcare facilities and cancer treatment centers are established, the demand for aprepitant is expected to rise. Ongoing research and development activities aimed at exploring new indications and formulations for aprepitant are further driving the market. For example, studies are being conducted to evaluate the efficacy of aprepitant in other conditions associated with nausea and vomiting, such as postoperative nausea and vomiting.
This report aims to provide a comprehensive presentation of the global market for Aprepitant, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Aprepitant.
Report Scope
The Aprepitant market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Aprepitant market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Aprepitant manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck & Co.
Heron Therapeutics
Sandoz
Glenmark Pharmaceuticals
Shanghai Yingrui Biomedical Technology Co., Ltd.
Vea Impex (I) Pvt. Ltd.
Aark Pharmaceuticals
Actiza Pharmaceutical
Aetos Pharma
Segment by Type
Injection
Oral
Segment by Application
Hospital
Drug store
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Aprepitant manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Aprepitant in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Aprepitant Market Overview
1.1 Product Overview and Scope of Aprepitant
1.2 Aprepitant Segment by Type
1.2.1 Global Aprepitant Market Value Comparison by Type (2024-2030)
1.2.2 Injection
1.2.3 Oral
1.3 Aprepitant Segment by Application
1.3.1 Global Aprepitant Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Drug store
1.4 Global Aprepitant Market Size Estimates and Forecasts
1.4.1 Global Aprepitant Revenue 2019-2030
1.4.2 Global Aprepitant Sales 2019-2030
1.4.3 Global Aprepitant Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Aprepitant Market Competition by Manufacturers
2.1 Global Aprepitant Sales Market Share by Manufacturers (2019-2024)
2.2 Global Aprepitant Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Aprepitant Average Price by Manufacturers (2019-2024)
2.4 Global Aprepitant Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Aprepitant, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Aprepitant, Product Type & Application
2.7 Aprepitant Market Competitive Situation and Trends
2.7.1 Aprepitant Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Aprepitant Players Market Share by Revenue
2.7.3 Global Aprepitant Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Aprepitant Retrospective Market Scenario by Region
3.1 Global Aprepitant Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Aprepitant Global Aprepitant Sales by Region: 2019-2030
3.2.1 Global Aprepitant Sales by Region: 2019-2024
3.2.2 Global Aprepitant Sales by Region: 2025-2030
3.3 Global Aprepitant Global Aprepitant Revenue by Region: 2019-2030
3.3.1 Global Aprepitant Revenue by Region: 2019-2024
3.3.2 Global Aprepitant Revenue by Region: 2025-2030
3.4 North America Aprepitant Market Facts & Figures by Country
3.4.1 North America Aprepitant Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Aprepitant Sales by Country (2019-2030)
3.4.3 North America Aprepitant Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Aprepitant Market Facts & Figures by Country
3.5.1 Europe Aprepitant Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Aprepitant Sales by Country (2019-2030)
3.5.3 Europe Aprepitant Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Aprepitant Market Facts & Figures by Country
3.6.1 Asia Pacific Aprepitant Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Aprepitant Sales by Country (2019-2030)
3.6.3 Asia Pacific Aprepitant Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Aprepitant Market Facts & Figures by Country
3.7.1 Latin America Aprepitant Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Aprepitant Sales by Country (2019-2030)
3.7.3 Latin America Aprepitant Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Aprepitant Market Facts & Figures by Country
3.8.1 Middle East and Africa Aprepitant Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Aprepitant Sales by Country (2019-2030)
3.8.3 Middle East and Africa Aprepitant Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Aprepitant Sales by Type (2019-2030)
4.1.1 Global Aprepitant Sales by Type (2019-2024)
4.1.2 Global Aprepitant Sales by Type (2025-2030)
4.1.3 Global Aprepitant Sales Market Share by Type (2019-2030)
4.2 Global Aprepitant Revenue by Type (2019-2030)
4.2.1 Global Aprepitant Revenue by Type (2019-2024)
4.2.2 Global Aprepitant Revenue by Type (2025-2030)
4.2.3 Global Aprepitant Revenue Market Share by Type (2019-2030)
4.3 Global Aprepitant Price by Type (2019-2030)
5 Segment by Application
5.1 Global Aprepitant Sales by Application (2019-2030)
5.1.1 Global Aprepitant Sales by Application (2019-2024)
5.1.2 Global Aprepitant Sales by Application (2025-2030)
5.1.3 Global Aprepitant Sales Market Share by Application (2019-2030)
5.2 Global Aprepitant Revenue by Application (2019-2030)
5.2.1 Global Aprepitant Revenue by Application (2019-2024)
5.2.2 Global Aprepitant Revenue by Application (2025-2030)
5.2.3 Global Aprepitant Revenue Market Share by Application (2019-2030)
5.3 Global Aprepitant Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Merck & Co.
6.1.1 Merck & Co. Corporation Information
6.1.2 Merck & Co. Description and Business Overview
6.1.3 Merck & Co. Aprepitant Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Merck & Co. Aprepitant Product Portfolio
6.1.5 Merck & Co. Recent Developments/Updates
6.2 Heron Therapeutics
6.2.1 Heron Therapeutics Corporation Information
6.2.2 Heron Therapeutics Description and Business Overview
6.2.3 Heron Therapeutics Aprepitant Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Heron Therapeutics Aprepitant Product Portfolio
6.2.5 Heron Therapeutics Recent Developments/Updates
6.3 Sandoz
6.3.1 Sandoz Corporation Information
6.3.2 Sandoz Description and Business Overview
6.3.3 Sandoz Aprepitant Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Sandoz Aprepitant Product Portfolio
6.3.5 Sandoz Recent Developments/Updates
6.4 Glenmark Pharmaceuticals
6.4.1 Glenmark Pharmaceuticals Corporation Information
6.4.2 Glenmark Pharmaceuticals Description and Business Overview
6.4.3 Glenmark Pharmaceuticals Aprepitant Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Glenmark Pharmaceuticals Aprepitant Product Portfolio
6.4.5 Glenmark Pharmaceuticals Recent Developments/Updates
6.5 Shanghai Yingrui Biomedical Technology Co., Ltd.
6.5.1 Shanghai Yingrui Biomedical Technology Co., Ltd. Corporation Information
6.5.2 Shanghai Yingrui Biomedical Technology Co., Ltd. Description and Business Overview
6.5.3 Shanghai Yingrui Biomedical Technology Co., Ltd. Aprepitant Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Shanghai Yingrui Biomedical Technology Co., Ltd. Aprepitant Product Portfolio
6.5.5 Shanghai Yingrui Biomedical Technology Co., Ltd. Recent Developments/Updates
6.6 Vea Impex (I) Pvt. Ltd.
6.6.1 Vea Impex (I) Pvt. Ltd. Corporation Information
6.6.2 Vea Impex (I) Pvt. Ltd. Description and Business Overview
6.6.3 Vea Impex (I) Pvt. Ltd. Aprepitant Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Vea Impex (I) Pvt. Ltd. Aprepitant Product Portfolio
6.6.5 Vea Impex (I) Pvt. Ltd. Recent Developments/Updates
6.7 Aark Pharmaceuticals
6.6.1 Aark Pharmaceuticals Corporation Information
6.6.2 Aark Pharmaceuticals Description and Business Overview
6.6.3 Aark Pharmaceuticals Aprepitant Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Aark Pharmaceuticals Aprepitant Product Portfolio
6.7.5 Aark Pharmaceuticals Recent Developments/Updates
6.8 Actiza Pharmaceutical
6.8.1 Actiza Pharmaceutical Corporation Information
6.8.2 Actiza Pharmaceutical Description and Business Overview
6.8.3 Actiza Pharmaceutical Aprepitant Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Actiza Pharmaceutical Aprepitant Product Portfolio
6.8.5 Actiza Pharmaceutical Recent Developments/Updates
6.9 Aetos Pharma
6.9.1 Aetos Pharma Corporation Information
6.9.2 Aetos Pharma Description and Business Overview
6.9.3 Aetos Pharma Aprepitant Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Aetos Pharma Aprepitant Product Portfolio
6.9.5 Aetos Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Aprepitant Industry Chain Analysis
7.2 Aprepitant Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Aprepitant Production Mode & Process
7.4 Aprepitant Sales and Marketing
7.4.1 Aprepitant Sales Channels
7.4.2 Aprepitant Distributors
7.5 Aprepitant Customers
8 Aprepitant Market Dynamics
8.1 Aprepitant Industry Trends
8.2 Aprepitant Market Drivers
8.3 Aprepitant Market Challenges
8.4 Aprepitant Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Aprepitant Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Aprepitant Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Aprepitant Market Competitive Situation by Manufacturers in 2023
Table 4. Global Aprepitant Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Aprepitant Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Aprepitant Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Aprepitant Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Aprepitant Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Aprepitant, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Aprepitant, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Aprepitant, Product Type & Application
Table 12. Global Key Manufacturers of Aprepitant, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Aprepitant by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Aprepitant as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Aprepitant Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Aprepitant Sales by Region (2019-2024) & (K Units)
Table 18. Global Aprepitant Sales Market Share by Region (2019-2024)
Table 19. Global Aprepitant Sales by Region (2025-2030) & (K Units)
Table 20. Global Aprepitant Sales Market Share by Region (2025-2030)
Table 21. Global Aprepitant Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Aprepitant Revenue Market Share by Region (2019-2024)
Table 23. Global Aprepitant Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Aprepitant Revenue Market Share by Region (2025-2030)
Table 25. North America Aprepitant Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Aprepitant Sales by Country (2019-2024) & (K Units)
Table 27. North America Aprepitant Sales by Country (2025-2030) & (K Units)
Table 28. North America Aprepitant Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Aprepitant Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Aprepitant Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Aprepitant Sales by Country (2019-2024) & (K Units)
Table 32. Europe Aprepitant Sales by Country (2025-2030) & (K Units)
Table 33. Europe Aprepitant Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Aprepitant Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Aprepitant Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Aprepitant Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Aprepitant Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Aprepitant Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Aprepitant Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Aprepitant Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Aprepitant Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Aprepitant Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Aprepitant Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Aprepitant Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Aprepitant Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Aprepitant Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Aprepitant Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Aprepitant Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Aprepitant Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Aprepitant Sales (K Units) by Type (2019-2024)
Table 51. Global Aprepitant Sales (K Units) by Type (2025-2030)
Table 52. Global Aprepitant Sales Market Share by Type (2019-2024)
Table 53. Global Aprepitant Sales Market Share by Type (2025-2030)
Table 54. Global Aprepitant Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Aprepitant Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Aprepitant Revenue Market Share by Type (2019-2024)
Table 57. Global Aprepitant Revenue Market Share by Type (2025-2030)
Table 58. Global Aprepitant Price (USD/Unit) by Type (2019-2024)
Table 59. Global Aprepitant Price (USD/Unit) by Type (2025-2030)
Table 60. Global Aprepitant Sales (K Units) by Application (2019-2024)
Table 61. Global Aprepitant Sales (K Units) by Application (2025-2030)
Table 62. Global Aprepitant Sales Market Share by Application (2019-2024)
Table 63. Global Aprepitant Sales Market Share by Application (2025-2030)
Table 64. Global Aprepitant Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Aprepitant Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Aprepitant Revenue Market Share by Application (2019-2024)
Table 67. Global Aprepitant Revenue Market Share by Application (2025-2030)
Table 68. Global Aprepitant Price (USD/Unit) by Application (2019-2024)
Table 69. Global Aprepitant Price (USD/Unit) by Application (2025-2030)
Table 70. Merck & Co. Corporation Information
Table 71. Merck & Co. Description and Business Overview
Table 72. Merck & Co. Aprepitant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Merck & Co. Aprepitant Product
Table 74. Merck & Co. Recent Developments/Updates
Table 75. Heron Therapeutics Corporation Information
Table 76. Heron Therapeutics Description and Business Overview
Table 77. Heron Therapeutics Aprepitant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Heron Therapeutics Aprepitant Product
Table 79. Heron Therapeutics Recent Developments/Updates
Table 80. Sandoz Corporation Information
Table 81. Sandoz Description and Business Overview
Table 82. Sandoz Aprepitant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Sandoz Aprepitant Product
Table 84. Sandoz Recent Developments/Updates
Table 85. Glenmark Pharmaceuticals Corporation Information
Table 86. Glenmark Pharmaceuticals Description and Business Overview
Table 87. Glenmark Pharmaceuticals Aprepitant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Glenmark Pharmaceuticals Aprepitant Product
Table 89. Glenmark Pharmaceuticals Recent Developments/Updates
Table 90. Shanghai Yingrui Biomedical Technology Co., Ltd. Corporation Information
Table 91. Shanghai Yingrui Biomedical Technology Co., Ltd. Description and Business Overview
Table 92. Shanghai Yingrui Biomedical Technology Co., Ltd. Aprepitant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Shanghai Yingrui Biomedical Technology Co., Ltd. Aprepitant Product
Table 94. Shanghai Yingrui Biomedical Technology Co., Ltd. Recent Developments/Updates
Table 95. Vea Impex (I) Pvt. Ltd. Corporation Information
Table 96. Vea Impex (I) Pvt. Ltd. Description and Business Overview
Table 97. Vea Impex (I) Pvt. Ltd. Aprepitant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Vea Impex (I) Pvt. Ltd. Aprepitant Product
Table 99. Vea Impex (I) Pvt. Ltd. Recent Developments/Updates
Table 100. Aark Pharmaceuticals Corporation Information
Table 101. Aark Pharmaceuticals Description and Business Overview
Table 102. Aark Pharmaceuticals Aprepitant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Aark Pharmaceuticals Aprepitant Product
Table 104. Aark Pharmaceuticals Recent Developments/Updates
Table 105. Actiza Pharmaceutical Corporation Information
Table 106. Actiza Pharmaceutical Description and Business Overview
Table 107. Actiza Pharmaceutical Aprepitant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. Actiza Pharmaceutical Aprepitant Product
Table 109. Actiza Pharmaceutical Recent Developments/Updates
Table 110. Aetos Pharma Corporation Information
Table 111. Aetos Pharma Description and Business Overview
Table 112. Aetos Pharma Aprepitant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. Aetos Pharma Aprepitant Product
Table 114. Aetos Pharma Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Aprepitant Distributors List
Table 118. Aprepitant Customers List
Table 119. Aprepitant Market Trends
Table 120. Aprepitant Market Drivers
Table 121. Aprepitant Market Challenges
Table 122. Aprepitant Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Aprepitant
Figure 2. Global Aprepitant Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Aprepitant Market Share by Type in 2023 & 2030
Figure 4. Injection Product Picture
Figure 5. Oral Product Picture
Figure 6. Global Aprepitant Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Aprepitant Market Share by Application in 2023 & 2030
Figure 8. Hospital
Figure 9. Drug store
Figure 10. Global Aprepitant Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Aprepitant Market Size (2019-2030) & (US$ Million)
Figure 12. Global Aprepitant Sales (2019-2030) & (K Units)
Figure 13. Global Aprepitant Average Price (USD/Unit) & (2019-2030)
Figure 14. Aprepitant Report Years Considered
Figure 15. Aprepitant Sales Share by Manufacturers in 2023
Figure 16. Global Aprepitant Revenue Share by Manufacturers in 2023
Figure 17. The Global 5 and 10 Largest Aprepitant Players: Market Share by Revenue in 2023
Figure 18. Aprepitant Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 19. Global Aprepitant Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 20. North America Aprepitant Sales Market Share by Country (2019-2030)
Figure 21. North America Aprepitant Revenue Market Share by Country (2019-2030)
Figure 22. U.S. Aprepitant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 23. Canada Aprepitant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Europe Aprepitant Sales Market Share by Country (2019-2030)
Figure 25. Europe Aprepitant Revenue Market Share by Country (2019-2030)
Figure 26. Germany Aprepitant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. France Aprepitant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. U.K. Aprepitant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Italy Aprepitant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Russia Aprepitant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Aprepitant Sales Market Share by Region (2019-2030)
Figure 32. Asia Pacific Aprepitant Revenue Market Share by Region (2019-2030)
Figure 33. China Aprepitant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Japan Aprepitant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. South Korea Aprepitant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. India Aprepitant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Australia Aprepitant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Taiwan Aprepitant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Indonesia Aprepitant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Thailand Aprepitant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Malaysia Aprepitant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Philippines Aprepitant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Aprepitant Sales Market Share by Country (2019-2030)
Figure 44. Latin America Aprepitant Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Aprepitant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Aprepitant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Aprepitant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Aprepitant Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Aprepitant Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Aprepitant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Aprepitant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. U.A.E Aprepitant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Aprepitant by Type (2019-2030)
Figure 54. Global Revenue Market Share of Aprepitant by Type (2019-2030)
Figure 55. Global Aprepitant Price (USD/Unit) by Type (2019-2030)
Figure 56. Global Sales Market Share of Aprepitant by Application (2019-2030)
Figure 57. Global Revenue Market Share of Aprepitant by Application (2019-2030)
Figure 58. Global Aprepitant Price (USD/Unit) by Application (2019-2030)
Figure 59. Aprepitant Value Chain
Figure 60. Aprepitant Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
